Original Research
Accepted on 29 Jul 2024
Metastatic disease and major adverse cardiovascular events (MACE) preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patients
in Adrenal Endocrinology